BUY IRAP ONLINE

We are delighted to introduce IRAP (Interleukin-1 Receptor Antagonist Protein), an advanced joint therapy designed to support equine performance, promote mobility, and enhance overall joint health.

Product Overview:
IRAP is a revolutionary injectable treatment that harnesses the power of your horse’s own natural healing mechanisms to address joint inflammation and promote joint health. This cutting-edge therapy utilizes Interleukin-1 Receptor Antagonist Protein, which is derived from the horse’s own blood, to combat the effects of inflammation and support optimal joint function.

Key Features and Benefits:

1. Natural Healing: IRAP harnesses the regenerative power of your horse’s own body to promote natural joint healing. By utilizing Interleukin-1 Receptor Antagonist Protein, IRAP helps counteract the inflammatory response within the joint, reducing pain and facilitating the repair process.
2. Joint Inflammation Reduction: IRAP is specifically designed to target and reduce joint inflammation, a common issue in equine athletes. By neutralizing the effects of Interleukin-1, a pro-inflammatory cytokine, IRAP helps alleviate pain, swelling, and stiffness, allowing your horse to move more comfortably.
3. Enhanced Joint Mobility: By promoting joint health and reducing inflammation, IRAP supports improved joint mobility and flexibility. This can have a significant impact on your horse’s performance, allowing for greater agility, range of motion, and overall athletic ability.
4. Long-Term Joint Health: IRAP offers long-term benefits for equine joint health. By addressing the underlying causes of joint inflammation, it helps protect the joint structures from further damage, supporting longevity and reducing the risk of future joint-related conditions.
5. Non-Invasive and Well-Tolerated: IRAP therapy is non-invasive and well-tolerated by horses. The treatment involves drawing a small amount of blood from your horse, processing it to concentrate the Interleukin-1 Receptor Antagonist Protein, and then injecting it back into the affected joint. This minimally invasive approach makes IRAP a popular choice for joint therapy.
6. Trusted Quality: At Equicurepharm, we prioritize the health and well-being of your horses. IRAP is produced using strict quality control measures, ensuring a reliable and premium product that meets the highest industry standards. We are committed to providing you with exceptional equine healthcare solutions.

Usage Instructions:
IRAP therapy should be administered by a licensed veterinarian who can assess your horse’s specific joint condition and recommend the appropriate treatment protocol. The veterinarian will guide you on the number and frequency of injections required for optimal results.

Please Note:

1. IRAP therapy is intended for equine use only and should not be used on other animals or humans.
2. Prior consultation with a veterinarian is essential before initiating any treatment with IRAP.
3. Adhere to the recommended treatment plan and follow the veterinarian’s instructions for optimal results.

Invest in the long-term joint health and performance of your equine partners with IRAP from Equicurepharm. Experience the remarkable benefits of this innovative joint therapy. Place your order today and provide your horses with the support they need to thrive.

Note: IRAP is a real therapy used in veterinary medicine, and the information provided here is based on general knowledge. Please consult with a veterinarian for specific details regarding IRAP therapy for your horse.

IRAP is a new and effective intra-articular treatment for joint disease marketed by Arthrex VetSystems in the USA.  The product was originally developed in Europe, and has been used extensively in Germany.  IRAP is an anti-inflammatory protein that counteracts the destructive effects of inflammatory proteins such as Interleukin-1 (IL-1) that are produced within inflamed or arthritic joints.  The  system has been designed to stimulate the horses’ own white blood cells to produce anti-inflammatory mediators and enzymes, specifically Interleukin 1 receptor antagonist protein (IRAP), which can reduce the inflammation present as a result of degenerative joint disease.  Treatment with IRAP utilizes progressive gene therapy to combat osteoarthritis in your horse.

The process of harvesting is quite simple and can be performed as an outpatient and/or potentially on the farm.  Blood is collected from the jugular vein and incubated for 24 hours in special syringes that contain glass beads that induce the white blood cells present in the blood to produce and secrete therapeutic proteins, namely, After 24 hours the blood is centrifuged and the serum is separated from the red blood cells. The protein rich serum is then split into 3-6ml doses and the separate doses are frozen for use at a later date

Typically each collection produces enough serum for between 3-5 injections. It is important to note that the injections are only suitable to treat the horse from which the original blood was collected. The injections can be stored for up to 12 months from the date of collection.

Degenerative joint disease is one of the biggest causes of poor performance and a decreased competitive lifespan in the horse. This is true for all types of equine athletes, from racehorses to dressage and show jumping horses. Both young and old horses can be affected by degenerative joint disease resulting in a loss of athletic ability and possible early retirement.

When injected into a joint, the IRAP protein rich serum stimulates a response from cartilage cells, through a process of cell division and increased cell recruitment. This is actually what sets IRAP apart from other intra-articular treatments for joint disease. The fact that IRAP stimulates cartilage cells means that it has a disease modifying component as well as an anti-inflammatory component. The serum also contains cytokines that act to reduce inflammation within the joint. In addition there are other anti-inflammatory proteins produced during the incubation process that work synergistically with the cytokines to further reduce the inflammation within the diseased joint.

What does the treatment with IRAP involve?

The therapy involves three joint injections at 7-14 day intervals. Most positive effects are seen after the second and the third treatment. The majority of horses will be sound after the third injection. In our hands, more than 90% of horses have returned to soundness after IRAP therapy. After injection, we routinely bandage the joint if possible for 2 days, and the horse should be kept on 3 days of strict stall rest, followed by a period of of hand-walking (30-45 minutes).  Once the course of injections and the final hand-walking period is completed, horses should receive one week of ridden walk exercise, followed by one week of ridden walk and trot, before returning gradually to regular training program